GSK’s Avodart / tamsulosin combination showed benefits for men with prostate enlargement

Links shared publicly online about this topic.

  • 1,682
    total visits

GSK’s Avodart / tamsulosin combination showed benefits for men with prostate enlargement

gsk.com

GSK’s Avodart / tamsulosin combination showed benefits for men with prostate enlargement

View full resource at gsk.com

Tags: Prostate, Benign Prostatic Hypertrophy Medication, Men's Health, Flomax, Harnal, Avodart, GlaxoSmithKline

  • Share

Most Recently Shared on October 12, 2009 at 3:17 pm By:

eyeonfda eyeonfda

GSK’s Avodart® / tamsulosin combination study results for men with prostate enlargement - http://bit.ly/mkqM7

3 years ago...

GSK development team tackles a new drug class at Yale - FierceBiotech

fiercebiotech.com — “GSK development team tackles a new drug class at Yale - FierceBiotechView full resource at fiercebiotech.com

  • View Related
  • Share

Most Recently Shared on May 1, 2012 at 1:59 pm By:

GlaxoSmithKline and Yale University establish drug discovery collaboration to design potential new class of medicines

us.gsk.com — “GlaxoSmithKline and Yale University establish drug discovery collaboration to design potential new class of medicinesView full resource at us.gsk.com

  • View Related
  • Share

Most Recently Shared on May 1, 2012 at 1:14 pm By:

eyeonfda eyeonfda Pharma and Health Lawyer

GSK and Yale University establish drug discovery collaboration to design potential new class of medicines http://t.co/J4nHClFb

2 weeks ago...

Votrient Gains Indication for Soft Tissue Sarcoma - MPR

empr.com — “GlaxoSmithKline announced that the FDA has approved Votrient (pazopanib) 200mg tablets for the treatment of patients with advanced soft tissue sarcoma (STS) who have received prior chemotherapyView full resource at empr.com

  • View Related
  • Share

Most Recently Shared on April 27, 2012 at 1:54 pm By:

eMPR MPR Medical Publisher

Votrient Gains Indication for Soft Tissue Sarcoma #gsk #oncology http://t.co/OcpMdGlq

2 weeks ago...

GSK says it the only obvious owner for Human Genome | Reuters

reuters.com — “LONDON (Reuters) - Drugmaker GlaxoSmithKline said on Wednesday its $2.6 billion bid for long-time partner Human Genome Sciences was full and fair and it was the only obvious owner for the biotechnologyView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on April 25, 2012 at 12:55 pm By:

Five Prime strikes deal with GSK for asthma drug - San Francisco Business Times

bizjournals.com — “Five Prime Therapeutics Inc., a South San Francisco-based biotechnology company,...View full resource at bizjournals.com

  • View Related
  • Share

Most Recently Shared on April 18, 2012 at 12:40 pm By:

In the News / EXCLUSIVE: Showtime has put in development The Angry Buddhist, a drama series project based on Seth Greenland’s of the same name. Novelist/playwright/screenwriter Greenland (HBO’s Big Love) will write the adaptation, from Anonymous Content.

pinterest.com — “In the News / EXCLUSIVE: Showtime has put in development The Angry Buddhist, a drama series project based on Seth Greenland’s of the same name. Novelist/playwright/screenwriter Greenland (HBO’s Big Love) will write the adaptation, from Anonymous Content. The drama with dark comedy elements is set in the high California desert. It centers on three brothers: a cop studying Buddhism, an unrepentant criminal and a wily U.S. Congressman running for his third term.View full resource at pinterest.com

  • View Related
  • Share

Most Recently Shared on April 18, 2012 at 12:34 am By:

sKAISERg SusanKaiserGreenland

http://t.co/r5ggjIKO EXCLUSIVE: Showtime has put in development @sethgreenland 's The Angry Buddhist. Greenland will write the adaptation.

4 weeks ago...

Auto Accidents | Asheville Pain and Wellness Center

necknbackpain.com — “Check out this interesting article by Dr. Terri Lechner at Asheville Pain and Wellness CenterView full resource at necknbackpain.com

  • View Related
  • Share

Most Recently Shared on April 11, 2012 at 1:19 pm By:

GSK to apply for FDA approval of diabetes drug albiglutide - Related Stories - DiabetesPro SmartBrief

smartbrief.com — “Diabetes patients who took GlaxoSmithKline's experimental once-weekly albiglutide attained lower body weight and blood glucose levels than those taking preprandial lispro insulin shots, the company said. GlaxoSmithKline said it has received top-line data from seven of eight Phase III clinical studi…View full resource at smartbrief.com

  • View Related
  • Share

Most Recently Shared on April 5, 2012 at 4:36 pm By:

AmDiabetesAL American Diabetes AL Health Organization

GSK to apply for FDA approval of diabetes drug albiglutide - DiabetesPro SmartBrief: http://t.co/4dySZDlS

1 month ago...

Never Spend Money on Things That Don’t Add Value to Your Life « Carolyn Anderson – Motivational Speaker, Entrepreneur & Doctor

carolynandersonmd.com — “Everything you buy should be essential or something you absolutely love that adds value to your life. A worthwhile investment contributes to the support of your body, mind and spirit.View full resource at carolynandersonmd.com

  • View Related
  • Share

Most Recently Shared on April 3, 2012 at 10:15 pm By:

DrCarolynAImpowerage. Mom to a 1.5 year old who enjoys staying active." /> Dr. Carolyn Anderson Active Health Library, Doctor, Surgeon, Ophthalmologist, and Physician

Never Spend Money on Things That Don’t Add Value to Your Life http://t.co/GSkE4QhU

1 month ago...

Navy Yard press kit - Media & News - GlaxoSmithKline

us.gsk.com — “Navy Yard press kitView full resource at us.gsk.com

  • View Related
  • Share

Most Recently Shared on March 27, 2012 at 4:17 pm By:

ChristianeTrue Christiane Truelove Health Communicator

RT @GSKUS: @Michael_Nutter, check out progress on GSK's new Navy Yard #greenbuilding on track for completion Q12013. http://t.co/G5Fi2CEw

2 months ago...

GSK grant supports STEM education for NC students :: STEM Education at WRAL Tech Wire

wraltechwire.com — “North Carolina's growing network of innovative STEM schools is getting a boost from a three-year, $750,000 grant from GlaxoSmithKline.View full resource at wraltechwire.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 5:20 pm By:

TheRTP RTP Science Enthusiast

PM RT @WRALTechWire: New blog post: GSK grant supports STEM education for NC students http://t.co/LuHsvlh0

2 months ago...

Relovair COPD and asthma filings on track despite more mixed trial results - Pharmaceutical and Biotechnology News - Pharma Letter

thepharmaletter.com — “As well as announcing new mixed clinical trial data, UK pharma giant GlaxoSmithKline (LSE: GSK) and US partner Theravance (Nasdaq: THRX) say that the registrational program for their investigational drug Relovair (fluticasone furoate and vilanterol (FF/VIView full resource at thepharmaletter.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 12:02 pm By:

wheezemd Michael Blaiss, MD Doctor, Allergist, and Physician

Relovair COPD and asthma filings on track despite more mixed trial results http://t.co/iccTfECw

2 months ago...

The Alpha Parent: Forward Facing Car Seats - a no brainer

thealphaparent.com — “The snobby side of parentingView full resource at thealphaparent.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 9:27 pm By:

GSK, J&J Join Index Ventures' Asset-Based $199M VC Fund - Drugs.com MedNews

drugs.com — “From BioWorld Today (March 22, 2012) LONDON - Spring has arrived on cue for European biotech with the launch of a new 150 million (US 199 million) venture capitView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 7:06 pm By:

Drugs_Devices Drugs and Devices OW OW Health

GSK, J&J Join Index Ventures' Asset-Based $199M VC Fund: From BioWorld Today (March 22, 2012) LONDON - Spr... http://t.co/NGPRpqfy #drug

2 months ago...

American Chemical Society - The world's largest scientific society.

abstracts.acs.org — “American Chemical Society - The world's largest scientific society.View full resource at abstracts.acs.org

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 3:13 pm By:

lisamjarvis Lisa Jarvis Science Enthusiast

Look for @carmendrahl live blog on Sun on 1st disclosures: $GSK's PI3Kb inh, $BMY's CGRP antag & NS5b inh, http://t.co/2DGdgthO #ACSSanDiego

2 months ago...

Advertisement